Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase

Antimicrob Agents Chemother. 2002 May;46(5):1540-5. doi: 10.1128/AAC.46.5.1540-1545.2002.

Abstract

Nucleotide-dependent unblocking of chain-terminated DNA by human immunodeficiency virus type 1 reverse transcriptase (RT) is enhanced by the presence of mutations associated with 3'-azido-3'-deoxythymidine (AZT) resistance. The increase in unblocking activity was greater for mutant combinations associated with higher levels of in vivo AZT resistance. The difference between mutant and wild-type activity was further enhanced by introduction of a methyl group into the nucleotide substrate and was decreased for a nonaromatic substrate, suggesting that pi-pi interactions between RT and an aromatic structure may be facilitated by these mutations.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antiviral Agents / pharmacology*
  • DNA Primers
  • Dinucleoside Phosphates / chemistry
  • Dinucleoside Phosphates / metabolism
  • Drug Resistance, Viral
  • HIV Reverse Transcriptase / drug effects
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / drug effects
  • HIV-1 / enzymology
  • Models, Molecular
  • Mutation*
  • Nucleotides / chemistry*
  • Nucleotides / metabolism
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Substrate Specificity
  • Templates, Genetic
  • Zidovudine / pharmacology*

Substances

  • Antiviral Agents
  • DNA Primers
  • Dinucleoside Phosphates
  • Nucleotides
  • Reverse Transcriptase Inhibitors
  • Zidovudine
  • HIV Reverse Transcriptase